(R)-(-)-Rolipram is a potent and cAMP-specific PDE4 inhibitor with IC50 of 0.22 uM: 2.5-fold more potent than (+)-rolipram (IC50= 2.58 uM) in inhibiting membrane-bound PDE 4.
(R)-(-)-Rolipram is a potent and cAMP-specific PDE4 inhibitor with IC50 of 0.22 uM: 2.5-fold more potent than (+)-rolipram (IC50= 2.58 uM) in inhibiting membrane-bound PDE 4.
(R)-(-)-Rolipram is a potent and cAMP-specific PDE4 inhibitor with IC50 of 0.22 uM: 2.5-fold more potent than (+)-rolipram (IC50= 2.58 uM) in inhibiting membrane-bound PDE 4.
(R)-(-)-Rolipram is a potent and cAMP-specific PDE4 inhibitor with IC50 of 0.22 uM: 2.5-fold more potent than (+)-rolipram (IC50= 2.58 uM) in inhibiting membrane-bound PDE 4.
Biochemical Test:SDS-PAGE (purity>: 80%): Western blot with monoclonal anti-GP2 antibody.Calculated Isoelectric Point:pH 5.4Coating Concentration:0.5-0.9 µg/ml (depending on the type of ELISA plate and coating buffer). Suitable for labeling of
Biochemical Test:SDS-PAGE (purity>: 80%): Western blot with monoclonal anti-GP2 antibody.Calculated Isoelectric Point:pH 5.4Coating Concentration:0.5-0.9 µg/ml (depending on the type of ELISA plate and coating buffer). Suitable for labeling of
Biochemical Test:SDS-PAGE (purity>: 80%): Western blot with monoclonal anti-GP2 antibody.Calculated Isoelectric Point:pH 5.4Coating Concentration:0.5-0.9 µg/ml (depending on the type of ELISA plate and coating buffer). Suitable for labeling of
Biochemical Test:SDS-PAGE (purity>: 80%): Western blot with monoclonal anti-GP2 antibody.Calculated Isoelectric Point:pH 5.4Coating Concentration:0.5-0.9 µg/ml (depending on the type of ELISA plate and coating buffer). Suitable for labeling of
(R)-BAY-899 is the R-enantiomer of BAY-899. BAY-899 is an orally active and selective luteinizing hormone receptor (LH-R) antagonist with IC50s of 185 nM and 46nM for hLH (human LH) and rLH (rat LH), respectively.Appearance:SolidBiological
(R)-BAY-899 is the R-enantiomer of BAY-899. BAY-899 is an orally active and selective luteinizing hormone receptor (LH-R) antagonist with IC50s of 185 nM and 46nM for hLH (human LH) and rLH (rat LH), respectively.Appearance:SolidBiological
(R)-BAY-899 is the R-enantiomer of BAY-899. BAY-899 is an orally active and selective luteinizing hormone receptor (LH-R) antagonist with IC50s of 185 nM and 46nM for hLH (human LH) and rLH (rat LH), respectively.Appearance:SolidBiological
(R)-BAY-899 is the R-enantiomer of BAY-899. BAY-899 is an orally active and selective luteinizing hormone receptor (LH-R) antagonist with IC50s of 185 nM and 46nM for hLH (human LH) and rLH (rat LH), respectively.Appearance:SolidBiological
(R)-BAY-899 is the R-enantiomer of BAY-899. BAY-899 is an orally active and selective luteinizing hormone receptor (LH-R) antagonist with IC50s of 185 nM and 46nM for hLH (human LH) and rLH (rat LH), respectively.Appearance:SolidBiological
(R)-BAY-899 is the R-enantiomer of BAY-899. BAY-899 is an orally active and selective luteinizing hormone receptor (LH-R) antagonist with IC50s of 185 nM and 46nM for hLH (human LH) and rLH (rat LH), respectively.Appearance:SolidBiological
(R)-BAY-899 is the R-enantiomer of BAY-899. BAY-899 is an orally active and selective luteinizing hormone receptor (LH-R) antagonist with IC50s of 185 nM and 46nM for hLH (human LH) and rLH (rat LH), respectively.Appearance:SolidBiological
(R)-BAY-899 is the R-enantiomer of BAY-899. BAY-899 is an orally active and selective luteinizing hormone receptor (LH-R) antagonist with IC50s of 185 nM and 46nM for hLH (human LH) and rLH (rat LH), respectively.Appearance:SolidBiological